Compound Summary
L-serine
Compound Information
L-serine
Compound Name: | L-serine |
Compound CID: | 5951 |
Synonyms: | L-serine serine 56-45-1 (S)-2-Amino-3-hydroxypropanoic acid (S)-Serine More... |
Iupac Name: | (2S)-2-amino-3-hydroxypropanoic acid |
InChI: | InChI=1S/C3H7NO3/c4-2(1-5)3(6)7/h2,5H,1,4H2,(H,6,7)/t2-/m0/s1 |
InChIKey: | MTCFGRXMJLQNBG-REOHCLBHSA-N |
Canonical Smiles: | C(C(C(=O)O)N)O |
Isomeric Smiles: | C([C@@H](C(=O)O)N)O |
Molecular Weight: | 105.09 |
Molecular Formula: | C3H7NO3 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
L-serine
Molecular Weight: | 105.09 |
Molecular Formula: | C3H7NO3 |
Hydrogen Bond Donor Count: | 3 |
Hydrogen Bond Acceptor Count: | 4 |
Rotatable Bond Count: | 2 |
Heavy Atom Count: | 7 |
Complexity: | 72.6 |
Synonyms
L-serine
| L-serine | L-serine |
|---|---|
L-serine |
serine |
56-45-1 |
(S)-2-Amino-3-hydroxypropanoic acid |
(S)-Serine |
H-Ser-OH |
beta-Hydroxyalanine |
L-ser |
L-Serin |
L-(-)-Serine |
Serine, L- |
(2S)-2-amino-3-hydroxypropanoic acid |
Serinum Latin |
Serina Spanish |
Serine (VAN) |
2-Amino-3-hydroxypropionic acid |
L-3-Hydroxy-alanine |
(-)-Serine |
beta-Hydroxy-L-alanine |
L-2-Amino-3-hydroxypropionic acid |
Serine USAN:INN |
SER (IUPAC abbrev) |
alpha-Amino-beta-hydroxypropionic acid |
L-3-Hydroxy-2-aminopropionic acid |
(S)-2-Amino-3-hydroxypropionic acid |
HSDB 680 |
(S)-(-)-Serine |
2-Amino-3-hydroxypropanoic acid, (S)- |
Propanoic acid, 2-amino-3-hydroxy-, (S)- |
MFCD00064224 |
BRN 1721404 |
ser |
UNII-452VLY9402 |
CHEBI:17115 |
(S)-alpha-Amino-beta-hydroxypropionic acid |
Serine (L-Serine) |
452VLY9402 |
(S)-2-amino-3-hydroxy-Propanoic acid |
(S)-(+)-2-Amino-3-hydroxypropionic acid |
Serinum |
Serene |
Serina |
.beta.-Hydroxyalanine |
b-Hydroxy-L-alanine |
6898-95-9 |
EINECS 200-274-3 |
NSC 118365 |
rac-serine |
Racemic serine |
2-amino-3-hydroxypropanoate |
NSC-118365 |
3h-l-serine |
L-Serine; |
H-Ser |
(S)-a-Amino-b-hydroxypropionic acid |
Serine (USP) |
3-hydroxy-L-Alanine |
L-Serine,(S) |
Tocris-0226 |
Tocris-0227 |
L-Serine (JP17) |
L-Alanine, 3-hydroxy- |
Lopac-S-4250 |
(L)-SERINE |
bmse000048 |
bmse000809 |
bmse000867 |
bmse000885 |
Epitope ID:150900 |
EC 200-274-3 |
SCHEMBL1775 |
GTPL726 |
4-04-00-03118 (Beilstein Handbook Reference) |
CHEMBL11298 |
L-3-Hydroxy-2-aminopropionate |
L-Serine, Cell Culture Reagent |
(S)-a-Amino-b-hydroxypropionate |
(S)-b-Amino-3-hydroxypropionate |
DTXSID60883230 |
(S)-2-Amino-3-hydroxypropanoate |
Pharmakon1600-01301010 |
ZINC895034 |
L-Serine - CAS 56-45-1 |
(S)-2-amino-3-hydroxy-Propanoate |
ACT08366 |
HY-N0650 |
L-2-Amino-3-hydroxypropanoic Acid |
L-Serine, Vetec(TM), 98.5% |
STR02557 |
(S)-beta-Amino-3-hydroxypropionate |
Fmoc-(2-aminomethylphenyl)aceticacid |
l-2-Amino-3-hydroxy-propanoic acid |
L-Serine, >=99.0% (NT) |
BDBM50357212 |
NSC760115 |
(S)-b-Amino-3-hydroxypropionic acid |
AKOS015854115 |
(S)-alpha-Amino-beta-hydroxypropionate |
AC-1190 |
CCG-266038 |
CS-W020136 |
DB00133 |
EBD2198140 |
MCULE-5604658333 |
NSC-760115 |
VC30786 |
(S)-beta-Amino-3-hydroxypropionic acid |
L-Serine, tested according to Ph.Eur. |
(2S)-2-amino-3-hydroxypropanoic acid. |
NCGC00015952-01 |
NCGC00024507-01 |
NCGC00024507-02 |
BP-13282 |
L-Serine, BioUltra, >=99.5% (NT) |
SY002847 |
2-Amino-3-hydroxypropanoic acid-, (S)- |
AB0008559 |
DB-029983 |
Propanoic acid, 2-amino-3-hydroxy-, (S) |
AM20100375 |
S0035 |
S9353 |
L-Serine, ReagentPlus(R), >=99% (HPLC) |
L-Serine, Vetec(TM) reagent grade, >=99% |
A20660 |
C00065 |
D00016 |
88848-EP2289892A1 |
88848-EP2305825A1 |
064S224 |
Q183290 |
SR-01000597708 |
.alpha.-Amino-.beta.-hydroxypropionic acid-, (S)- |
SR-01000597708-1 |
L-Serine, certified reference material, TraceCERT(R) |
F1905-7047 |
Serine, European Pharmacopoeia (EP) Reference Standard |
Z1270387256 |
3AB40D3A-043A-488F-8361-D1BF309F842C |
UNII-00PAR1C66F component MTCFGRXMJLQNBG-REOHCLBHSA-N |
UNII-0O72R8RF8A component MTCFGRXMJLQNBG-REOHCLBHSA-N |
L-Serine, United States Pharmacopeia (USP) Reference Standard |
(s)-2-amino-3-hydroxypropanoicacid;2-Amion-3-hydroxypropionicacid |
L-Serine, Pharmaceutical Secondary Standard; Certified Reference Material |
L-Serine, from non-animal source, meets EP, USP testing specifications, suitable for cell culture, 98.5-101.0% |
L-Serine, PharmaGrade, Ajinomoto, EP, USP, JP, Manufactured under appropriate controls for use in pharma or biopharmaceutical production, suitable for cell culture |
L-Serine, PharmaGrade, Ajinomoto, EP, USP, manufactured under appropriate GMP controls for Pharma or Biopharmaceutical production, suitable for cell culture |
Experimental Data
L-serine
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 10.000000000000000 | mM | 22.000000000000000 | S | N2 | 25643626 | Active | ||||||
| Caenorhabditis elegans | 1.000000000000000 | mM | 8.000000000000000 | S | N2 | 25643626 | Active | ||||||
| Caenorhabditis elegans | 5.000000000000000 | mM | 18.000000000000000 | S | N2 | 25643626 | Active |
Experimental Data Visualization
L-serine
Statistics Data
L-serine
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | 22.000000000000000 | 1 | 3 |
Statistics Data Visualization
L-serine
